We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 21 JANUARY 2014
Health Canada And Federal Court Make Important Biologic Decisions
Smart & Biggar
Last week was a landmark for biologics in Canada: Health Canada approved two antibody subsequent entry biologics (SEBs) and the Federal Court issued a decision finding a patent directed at a therapeutic use of an antibody to be valid and infringed.
CanadaIntellectual Property




